个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies

  作者 DOCKENDORFF CHRIS; NAGIEC MAREK M; WEIWER MICHEL; BUHRLAGE SARA; TING AMAL; NAG PARTHA P; GERMAIN ANDREW; KIM HANJE; YOUNGSAYE WILLMEN; SCHERER CHRISTINA; BENNION MELISSA; XUE LINLONG; STANTON BENJAMIN Z; LEWIS TIMOTHY A; MACPHERSON LAWRENCE; PALMER MICHELLE; FOLEY MICHAEL A; PEREZ JOSE R; SCHREIBER STUART L  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2012年3-10;  页码  808-813  
  关联知识点  
 

[摘要]Macrocyclic Hedgehog (Hh) pathway inhibitors have been discovered with improved potency and maximal inhibition relative to the previously reported macrocycle robotnikinin. Analogues were prepared using a modular and efficient build-couple-pair (BCP) approach, with a ring-closing metathesis step to form the macrocyclic ring. Varying the position of the macrocycle nitrogen and oxygen atoms provided inhibitors with improved activity in cellular assays; the most potent analogue was 29 (BRD-6851), with an IC50 of 0.4 mu M against C3H10T1/2 cells undergoing Hh-induced activation, as measured by Gli1 transcription and alkaline phosphatase induction. Studies with Patched knockout (Ptch(-/-)) cells and competition studies with the Smoothened (Smo) agonists SAG and purmorphamine demonstrate that in contrast to robotnikinin, select analogues are Smo antagonists.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内